 |
Technetium Tc 99m Exametazime - Diagnostic use
Research News and Information
Definition of 'Technetium Tc 99m Exametazime'A gamma-emitting radionuclide imaging agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and myocardial imaging. It has also been used to label leukocytes in the investigation of inflammatory bowel diseases. Common names: Technetium Tc 99m Exametazime; 99mTc-HMPAO; Tc-99m HMPAO; Tc-99m-Hexamethylpropyleneamine Oxime; Oxime, Tc-99m-Hexamethylpropyleneamine; Tc 99m Hexamethylpropyleneamine Oxime; Technetium Tc 99m Hexamethylpropylene-amine Oxime; Technetium Tc 99m Hexamethylpropylene amine Oxime |
Sunday, November 22, 2009
30 Aug 2009 
PURPOSE: To evaluate the ability of polymeric nanocapsules (NCs) radiolabeled with technetium-99m D,L-hexamethylpropyleneamine oxime (Tc-HMPAO) to identify inflammatory process in an experimental model. METHODS: NCs were prepared by interfacial ... Read more...
Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome.
13 Jul 2009 The aim of this article is to compare patients with Alzheimer's disease (AD) pathology and corticobasal degeneration pathology (CBD) presenting as corticobasal syndrome (CBS). Clinicopathologic series was used. Five patients with AD and 11 patients ... Read more...
29 Jun 2009 A case of idiopathic basal ganglia calcification in a 56-year-old woman with parkinsonism and cognitive impairment is described. The nigrostriatal dopaminergic pathway and regional cerebral blood flow were evaluated using dopamine transporter (DAT) ... Read more...
Latest indexed articles for 'Technetium Tc 99m Exametazime - Diagnostic use'
These are the very latest articles for this heading:
- Biodistribution study and identification of inflammatory sites using nanocapsules labeled with (99m)Tc-HMPAO. 30 Aug 2009
- False positive uptake of cavernous hemangioma with Tc-99m HMPAO-labeled leukocytes.
30 Jul 2009 - Alzheimer's disease and corticobasal degeneration presenting as corticobasal syndrome. 13 Jul 2009
- Dopamine transporter SPECT/CT and perfusion brain SPECT imaging in idiopathic basal ganglia calcinosis. 29 Jun 2009
- Diabetic foot infection: usefulness of SPECT/CT for 99mTc-HMPAO-labeled leukocyte imaging. 10 Jun 2009
- Current concepts review: diagnostic imaging of the diabetic foot. 30 May 2009
- 99-mTc-HMPAO single photon emission computed tomography examinations in genetically determined neurometabolic disorders. 28 May 2009
- Pictures in clinical medicine. Recovery of cerebral blood perfusion from transient hypo-perfusion due to acute benzodiazepine poisoning coinciding with generalized convulsion as withdrawal syndrome.
13 May 2009 - Principal component analysis in mild and moderate Alzheimer's disease--a novel approach to clinical diagnosis. 12 May 2009
- Diagnostic performance of Tc-99m HMPAO SPECT for early and late onset Alzheimer's disease: a clinical evaluation of linearization correction. 10 May 2009
- [Incidental finding of bone marrow metastatic dissemination in the (99m)Tc-HMPAO-leukocyte scintigraphy] 29 Apr 2009
- Tc-99m HMPAO-SPECT with CT attenuation correction improves detection of epileptogenic areas. 29 Apr 2009
- Successful surgery in late onset epilepsy with tuberous sclerosis complex. 27 Feb 2009
- [Brain perfusion image with a portable mini-gamma camera (Sentinella) in brain death] 27 Feb 2009
- Nanoradioliposomes molecularly modulated to study the lung deep lymphatic drainage. 27 Feb 2009
- Staged angioplasty for carotid artery stenosis to prevent postoperative hyperperfusion. 27 Feb 2009
- Abnormal brain response to cholinergic challenge in chronic encephalopathy from the 1991 Gulf War. 18 Feb 2009
- Changes in regional cerebral blood flow after body image exposure in eating disorders. 22 Jan 2009
- [Algodystrophy versus postoperative infection: use of labelled white cell scans in differential diagnosis in the hand; a case report] 7 Jan 2009
- Autologous bone-marrow mononuclear cell transplantation after acute myocardial infarction: comparison of two delivery techniques. 30 Dec 2008
See a longer list of these articles.
Technical information about 'Technetium Tc 99m Exametazime'
Definition: A gamma-emitting radionuclide imaging agent used in the evaluation of regional cerebral blood flow and in non-invasive dynamic biodistribution studies and myocardial imaging. It has also been used to label leukocytes in the investigation of inflammatory bowel diseases.
Registry Number: 100504-35-6
Descriptor UI: D019690
Alternative terms: Technetium Tc 99m Exametazime; 99mTc-HMPAO; Tc-99m HMPAO; Tc-99m-Hexamethylpropyleneamine Oxime; Oxime, Tc-99m-Hexamethylpropyleneamine; Tc 99m Hexamethylpropyleneamine Oxime; Technetium Tc 99m Hexamethylpropylene-amine Oxime; Technetium Tc 99m Hexamethylpropylene amine Oxime; Technetium Tc 99m Hexamethylpropyleneamine Oxime; 99m-Tc-HMPAO; Tc-99m-Exametazime; Tc 99m Exametazime; Ceretec;
Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;
Pharmacological Action: Radiopharmaceuticals;
Tree Number: D02.092.570.665.810; D02.691.825.562;
History Note: 98; see TECHNETIUM TC 99M EXAMETAZIME (NM) 1985-97
Technical Notes: as label, use /diag use; DF: TC HMPAO